Propofol combined with lorazepam for severe poly substance misuse and withdrawal states in intensive care unit: A case series and review

Emergency Medicine Journal

Volumn 21, Issue 5, 2004, Pages 632-634

  Subramaniam, Kathirvels ^a,b   Gowda, R M ^a   Jani, K ^a   Zewedie, W ^a   Ute, R ^a  

^a LONG ISLAND COLLEGE HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BRONCHODILATING AGENT; CHLORDIAZEPOXIDE; CORTICOSTEROID; HALOPERIDOL; LORAZEPAM; METHADONE; PROPOFOL;

ADULT; ALCOHOLISM; ARTICLE; ASTHMA; CASE REPORT; CELLULITIS; DISEASE SEVERITY; DRUG DETOXIFICATION; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; MENTAL DISEASE; PNEUMONIA; PRIORITY JOURNAL; SEDATION; SUBSTANCE ABUSE; SYMPTOMATOLOGY; WITHDRAWAL SYNDROME;

ADULT; ANESTHETICS, INTRAVENOUS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; INTENSIVE CARE; LORAZEPAM; MALE; PROPOFOL; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 4544237559     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2003.007526     Document Type: Article

References (29)

1. Holland P, Mushinski M. Costs of alcohol and drug abuse in the United States, 1992. Alcohol/Drugs COI Study Team. Stat Bull Metrop Insur Co 1999;80:2-9.
2. Fingerwood MI. Illicit and therapeutic use of drugs with abuse liability. In: Barker LR, Burton JR, Zieve PD, eds. Principles of ambulatory medicine. Maryland: Williams and Wilkins, 1999:264-88.
3. Smith I, White PF, Nathanson M, et al. Propofol: an update on its clinical use. Anesthesiology 1994;81:1005-45.
4. Yost DA. Alcohol withdrawal syndrome. Am Fam Physician 1996;54:657-64.
5. Wolf KM, Shaughnessy AF, Middleton DB. Prolonged delirium tremens requiring massive doses of medication. J Am Board Fam Pract 1993;6:502-4.
6. Nolop KB, Natow A. Unprecedented sedative requirements during delirium tremens. Crit Care Med 1985;13:246-7.
7. Miller FT. Protracted alcohol withdrawal delirium. Subst Abuse Treat 1994;11:127-30.
8. McCowan C, Marik P. Refractory delirium tremens treated with propofol: a case series. Crit Care Med 2000;28:1781-4.
9. Mirski MA, Muffelman B, Ulatowski JA, et al. Sedation for the critically ill neurologic patient. Crit Care Med 1995;23:2038-53.
10. Laine GA, Hossain SM, Solis RT, et al. Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam. Ann Pharmacother 1995;29:1110-14.
11. Cowley MJ. Short-term lorazepam infusion and concern for propylene glycol toxicity: case report and review. Pharmacotherapy 2001;21:1140-4.
12. Coomes TR, Smith SW. Successful use of propofol in refractory delirium tremens. Ann Emerg Med 1997;30:825-8.
13. Orser BA, Bertlik M, Wang LY, et al. Inhibition of propofol of the NMDA subtype of glutamate receptor in cultured hippocampal neurons. Br J Pharmacol 1995;116:1761-8.
14. Davis KM, Wu JY. Role of glutamatergic and GABAergic systems in alcoholism. J Biomed Sci 2001;8:7-19.
15. Bisaga A, Popik P, Bespalov AY, et al. Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders. Expert Opin Investig Drugs 2000;9:2233-48.
16. Hensel M, Kox WJ. Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts. Acta Anaesthesiol Scand 2000;44:326-33.
17. Demaria PA Jr, Rodgers C, Braccia G. Propofol for sedation during rapid opiate detoxification. [Letter]. Am J Psychiatry 1997;154:290-1.
18. Ritson B, Chick J. Comparison of two benzodiazepines in the treatment of alcohol withdrawal. Drug Alcohol Depend 1986;18:329-34.
19. Carrasco G, Cabre L, Sobrepere G, et al. Synergistic sedation with propofol and midazolam in intensive care patients after coronary artery bypass grafting. Crit Care Med 1998;26:844-51.
20. Carrasco G, Molina R, Costa J, et al. Propofol and midazolam in short-, medium-, and long-term sedation of critically ill patients. Chest 1993;103:557-64.
21. Possidente CJ, Rogers FB, Osler TM, et al. Elevated pancreatic enzymes after extended propofol therapy. Pharmacotherapy 1998;18:653-5.
22. Perrier ND, Baerga-Varela Y, Murray MJ. Death related to propofol use in an adult patient. Crit Care Med 2000;28:3071-4.
23. Islander G, Vinge E. Severe neuroexcitatory symptoms after anaesthesia-with focus on propofol anaesthesia. Acta Anaesthesiol Scand 2000;44:144-9.
24. Currier DS, Bevacqua BK. Acute tachyphylaxis to propofol sedation during ethanol withdrawal. J Clin Anesth 1997;9:420-3.
25. Hendelsman L, Cochrane KJ, Aronson MJ, et al. Two new rating scales for opiate withdrawal. Am J Drug Alcohol Abuse 1987;38:159-66.
26. Sullivan JT, Sykora K, Schneiderman J, et al. Assessment of alcohol withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). Br J Addiction 1989;84:1353-7.
27. Spies CD, Dubisz N, Neumann T, et al. Therapy of alcohol withdrawal syndrome in intensive care unit patients following trauma: results of a prospective, randomized trial. Crit Care Med 1996;24:414-22.
28. Lohr RH. Treatment of alcohol withdrawal in hospitalized patients. Mayo Clin Proc 1995;70:777-82.
29. Crippen DW. Strategies for managing delirium tremens in the ICU. J Crit Illness 1997;12:140-9.